Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |